Literature DB >> 1740613

The music therapy assessment tool in Alzheimer's patients.

N J Glynn.   

Abstract

1. Empirical research is needed to evaluate immediate and sustained physiological, psychological, and psychosocial therapeutic effects, if any, of music therapy on behavioral patterns of elderly institutionalized Alzheimer's patients. 2. The Music Therapy Assessment Tool (MTAT) was specifically designed and developed to assess the effects of music therapy on behavioral patterns of Alzheimer's disease patients. 3. Preliminary testing of the MTAT suggests that it has fairly high internal consistency and inter-rater reliability and warrants consideration as a research tool. 4. Musical intervention included familiar music to facilitate communication and socialization, ethnic and nostalgic music to stimulate reminiscence, and melodies with distinctive rhythmic patterns to enhance movement and behavioral repatterning.

Entities:  

Mesh:

Year:  1992        PMID: 1740613     DOI: 10.3928/0098-9134-19920101-03

Source DB:  PubMed          Journal:  J Gerontol Nurs        ISSN: 0098-9134            Impact factor:   1.254


  4 in total

Review 1.  A systematic review of the use of technology for reminiscence therapy.

Authors:  Amanda Lazar; Hilaire Thompson; George Demiris
Journal:  Health Educ Behav       Date:  2014-10

2.  Behavioral and psychological signs and symptoms of dementia: a practicing psychiatrist's viewpoint.

Authors:  J E Mintzer; D F Mirski; K S Hoernig
Journal:  Dialogues Clin Neurosci       Date:  2000-06       Impact factor: 5.986

3.  Musical Electroacupuncture May Be a Better Choice than Electroacupuncture in a Mouse Model of Alzheimer's Disease.

Authors:  Jing Jiang; Gang Liu; Suhua Shi; Zhigang Li
Journal:  Neural Plast       Date:  2016-11-16       Impact factor: 3.599

4.  The development of Music in Dementia Assessment Scales (MiDAS).

Authors:  Orii McDermott; Martin Orrell; Hanne Mette Ridder
Journal:  Nord J Music Ther       Date:  2014-05-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.